Cargando…

Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?

Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic varia...

Descripción completa

Detalles Bibliográficos
Autores principales: Podwika, Sarah E., Jenkins, Taylor M., Khokhar, Joyti K., Erickson, Sarah H., Modesitt, Susan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201186/
https://www.ncbi.nlm.nih.gov/pubmed/32382648
http://dx.doi.org/10.1016/j.gore.2020.100569
_version_ 1783529494337814528
author Podwika, Sarah E.
Jenkins, Taylor M.
Khokhar, Joyti K.
Erickson, Sarah H.
Modesitt, Susan C.
author_facet Podwika, Sarah E.
Jenkins, Taylor M.
Khokhar, Joyti K.
Erickson, Sarah H.
Modesitt, Susan C.
author_sort Podwika, Sarah E.
collection PubMed
description Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic variants and the remainder demonstrating somatic SMARCA4 pathogenic variants. This case report discusses an illustrative case and explores the existing data and potential recommendations to optimize timing of genetic testing in family members, given the presence of a familial germline pathogenic variant.
format Online
Article
Text
id pubmed-7201186
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72011862020-05-07 Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? Podwika, Sarah E. Jenkins, Taylor M. Khokhar, Joyti K. Erickson, Sarah H. Modesitt, Susan C. Gynecol Oncol Rep Case Report Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic variants and the remainder demonstrating somatic SMARCA4 pathogenic variants. This case report discusses an illustrative case and explores the existing data and potential recommendations to optimize timing of genetic testing in family members, given the presence of a familial germline pathogenic variant. Elsevier 2020-04-07 /pmc/articles/PMC7201186/ /pubmed/32382648 http://dx.doi.org/10.1016/j.gore.2020.100569 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Podwika, Sarah E.
Jenkins, Taylor M.
Khokhar, Joyti K.
Erickson, Sarah H.
Modesitt, Susan C.
Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title_full Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title_fullStr Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title_full_unstemmed Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title_short Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
title_sort optimal age for genetic cancer predisposition testing in hereditary smarca4 ovarian cancer families: how young is too young?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201186/
https://www.ncbi.nlm.nih.gov/pubmed/32382648
http://dx.doi.org/10.1016/j.gore.2020.100569
work_keys_str_mv AT podwikasarahe optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung
AT jenkinstaylorm optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung
AT khokharjoytik optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung
AT ericksonsarahh optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung
AT modesittsusanc optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung